---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-071011"
form_type: "8-K"
ticker: "ANVS"
cik: "0001477845"
company_name: "Annovis Bio, Inc."
filed_at: "2024-06-13T23:59:59+00:00"
generated_at: "2026-06-01T04:35:30.181154+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Annovis Bio stockholders elect directors, approve equity plan amendment, ratify auditors at annual meeting

## Summary
- All five director nominees elected; Michael Hoffman (3,856,586 for), Maria Maccecchini (3,888,261 for), Claudine Bruck, Reid McCarthy, Mark White.
- Amendment to 2019 Equity Incentive Plan approved, adding 1,000,000 shares to the share reserve.
- Ratification of Ernst & Young as independent auditor for FY2024 approved (7,214,275 for, 48,270 against).
- 66.10% of outstanding shares (7,278,396 shares) were represented at the meeting.

## SEC filing metadata
- accession: 0001104659-24-071011
- form_type: 8-K
- ticker: ANVS
- cik: 0001477845
- company_name: Annovis Bio, Inc.
- filed_at: 2024-06-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477845/000110465924071011/0001104659-24-071011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477845/000110465924071011/tm2417098d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-071011
- JSON: https://secwatch.observer/filing/0001104659-24-071011.json
- Plain text: https://secwatch.observer/filing/0001104659-24-071011.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.